The default category

Imagine Eyes selected for Bpifrance accelerator program

We are happy to share that Imagine Eyes is laureate for a second accelerator program in less than one year! This month,…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…

Deciphering AMD: cellular phenotyping & short term progression

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Imagine Eyes laureate of NEXT French Healthcare

We are happy to share that Imagine Eyes has been selected for NEXT French Healthcare, an acceleration program dedicated…

Experts discuss microvascular diseases and AO imaging

Discussion with 3 clinical experts on AO retinal imaging for diseases that alter small blood vessels.

Fighting IRDs: Adaptive Optics imaging perspectives

30min roundtable discussion with 3 clinical experts on the use of AO retinal imaging in inherited retinal diseases.

rtx1 users’ e-symposium 2021

Last week, Imagine Eyes held the first edition of the rtx1 users' e-symposium. Clinicians, researchers and ophthalmic photographers…

Clinical and animal findings with adaptive optics retinal cameras

In recent years, not only clinical investigators, but also animal researchers have increasingly adopted the rtx1 AO camera…

ARVO 2021: Phenotyping at the cellular level in the retina

This year at ARVO 2021, users of Imagine Eyes’ rtx1 report clinical and animal findings in several diseases. They present new phenotype information at the cellular level in the retina, obtained with adaptive optics imaging.

Adaptive optics findings in inherited retinal diseases

12 teams of ophthalmologists have published 28 studies that used the rtx1 Adaptive Optics Retinal Camera to investigate inherited…